129 related articles for article (PubMed ID: 36724139)
1. Survival of Patients With Inoperable Non-Small Cell Lung Cancer With Baseline Severe Pulmonary Dysfunction: Impacts of Thoracic Radiotherapy and Predictive Analysis for Acute Radiation Pneumonitis.
Deng Q; Zhang Y; Li Y; Mei T; Yang X; Tian X; Chen X; Gong Y
Oncology (Williston Park); 2023 Jan; 37(1):26-33. PubMed ID: 36724139
[TBL] [Abstract][Full Text] [Related]
2. Acute severe radiation pneumonitis among non-small cell lung cancer (NSCLC) patients with moderate pulmonary dysfunction receiving definitive concurrent chemoradiotherapy: Impact of pre-treatment pulmonary function parameters.
Zhou Y; Yan T; Zhou X; Cao P; Luo C; Zhou L; Xu Y; Liu Y; Xue J; Wang J; Wang Y; Lu Y; Liang B; Gong Y
Strahlenther Onkol; 2020 Jun; 196(6):505-514. PubMed ID: 31828393
[TBL] [Abstract][Full Text] [Related]
3. Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapy.
Shi A; Zhu G; Wu H; Yu R; Li F; Xu B
Radiat Oncol; 2010 May; 5():35. PubMed ID: 20462424
[TBL] [Abstract][Full Text] [Related]
4. Predicting severe acute radiation pneumonitis in patients with non-small cell lung cancer receiving postoperative radiotherapy: Development and internal validation of a nomogram based on the clinical and dose-volume histogram parameters.
Tang X; Li Y; Tian X; Zhou X; Wang Y; Huang M; Ren L; Zhou L; Xue J; Ding Z; Zhu J; Xu Y; Peng F; Wang J; Lu Y; Gong Y
Radiother Oncol; 2019 Mar; 132():197-203. PubMed ID: 30385172
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes and radiation pneumonitis after concurrent EGFR-tyrosine kinase inhibitors and radiotherapy for unresectable stage III non-small cell lung cancer.
Xu K; Liang J; Zhang T; Zhou Z; Chen D; Feng Q; Xiao Z; Hui Z; Lu J; Wang X; Deng L; Liu W; Wang J; Zhai Y; Wang J; Bi N; Wang L
Thorac Cancer; 2021 Mar; 12(6):814-823. PubMed ID: 33501781
[TBL] [Abstract][Full Text] [Related]
6. A little to a lot or a lot to a little? An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3-D conformal radiotherapy.
Willner J; Jost A; Baier K; Flentje M
Strahlenther Onkol; 2003 Aug; 179(8):548-56. PubMed ID: 14509954
[TBL] [Abstract][Full Text] [Related]
7. Symptomatic Radiation Pneumonitis in NSCLC Patients Receiving EGFR-TKIs and Concurrent Once-daily Thoracic Radiotherapy: Predicting the Value of Clinical and Dose-volume Histogram Parameters.
Yang X; Mei T; Yu M; Gong Y
Zhongguo Fei Ai Za Zhi; 2022 Jun; 25(6):409-419. PubMed ID: 35747920
[TBL] [Abstract][Full Text] [Related]
8. Risk factor analysis of the development of severe radiation pneumonitis in patients with non-small cell lung cancer treated with curative radiotherapy, with focus on underlying pulmonary disease.
Kim H; Hwang J; Kim SM; Choi J; Yang DS
BMC Cancer; 2023 Oct; 23(1):992. PubMed ID: 37848850
[TBL] [Abstract][Full Text] [Related]
9. Is pulmonary artery a dose-limiting organ at risk in non-small cell lung cancer patients treated with definitive radiotherapy?
Ma JT; Sun L; Sun X; Xiong ZC; Liu Y; Zhang SL; Huang LT; Han CB
Radiat Oncol; 2017 Feb; 12(1):34. PubMed ID: 28143532
[TBL] [Abstract][Full Text] [Related]
10. Inhalative steroids as an individual treatment in symptomatic lung cancer patients with radiation pneumonitis grade II after radiotherapy - a single-centre experience.
Henkenberens C; Janssen S; Lavae-Mokhtari M; Leni K; Meyer A; Christiansen H; Bremer M; Dickgreber N
Radiat Oncol; 2016 Feb; 11():12. PubMed ID: 26830686
[TBL] [Abstract][Full Text] [Related]
11. Clinical and Dosimetric Factors Predicting Grade ≥2 Radiation Pneumonitis After Postoperative Radiotherapy for Patients With Non-Small Cell Lung Carcinoma.
Boonyawan K; Gomez DR; Komaki R; Xu Y; Nantavithya C; Allen PK; Mohan R; Liao Z
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):919-926. PubMed ID: 29976504
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary emphysema is a risk factor for radiation pneumonitis in NSCLC patients with squamous cell carcinoma after thoracic radiation therapy.
Zhou Z; Song X; Wu A; Liu H; Wu H; Wu Q; Liu Y; Li Y; Cai Y; Liang S
Sci Rep; 2017 Jun; 7(1):2748. PubMed ID: 28584268
[TBL] [Abstract][Full Text] [Related]
13. Prognostic analysis of radiation pneumonitis: carbon-ion radiotherapy in patients with locally advanced lung cancer.
Hayashi K; Yamamoto N; Karube M; Nakajima M; Matsufuji N; Tsuji H; Ogawa K; Kamada T
Radiat Oncol; 2017 May; 12(1):91. PubMed ID: 28558766
[TBL] [Abstract][Full Text] [Related]
14. Radiation pneumonitis in lung cancer patients: a retrospective study of risk factors and the long-term prognosis.
Inoue A; Kunitoh H; Sekine I; Sumi M; Tokuuye K; Saijo N
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):649-55. PubMed ID: 11172945
[TBL] [Abstract][Full Text] [Related]
15. Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer.
Robnett TJ; Machtay M; Vines EF; McKenna MG; Algazy KM; McKenna WG
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):89-94. PubMed ID: 10924976
[TBL] [Abstract][Full Text] [Related]
16. Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy.
Ramella S; Trodella L; Mineo TC; Pompeo E; Stimato G; Gaudino D; Valentini V; Cellini F; Ciresa M; Fiore M; Piermattei A; Russo P; Cesario A; D'Angelillo RM
Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):110-5. PubMed ID: 19619955
[TBL] [Abstract][Full Text] [Related]
17. Analysis of clinical and physical dosimetric factors that determine the outcome of severe acute radiation pneumonitis in lung cancer patients.
Zhao J; Ma C; Gan G; Xu X; Zhou J
Radiat Oncol; 2023 Aug; 18(1):143. PubMed ID: 37644602
[TBL] [Abstract][Full Text] [Related]
18. High frequency of radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent radiotherapy and gemcitabine after induction with gemcitabine and carboplatin.
Arrieta O; Gallardo-Rincón D; Villarreal-Garza C; Michel RM; Astorga-Ramos AM; Martínez-Barrera L; de la Garza J
J Thorac Oncol; 2009 Jul; 4(7):845-52. PubMed ID: 19487963
[TBL] [Abstract][Full Text] [Related]
19. [Non-small cell lung cancer: risk factors of radiation pneumonitis].
Giroux Leprieur E; Fernandez D; Chatellier G; Klotz S; Giraud P; Durdux C
Cancer Radiother; 2012; 16(4):257-62. PubMed ID: 22748977
[TBL] [Abstract][Full Text] [Related]
20. Serum Amyloid P-component Level May be a Biomarker for Lung Toxicities and Overall Survival after Thoracic Radiotherapy for Non-small Cell Lung Cancer.
Zhao J; Chi A; Mao R; Hu G; Ji M
Clin Lab; 2016 Nov; 62(11):2183-2190. PubMed ID: 28164664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]